Design of two new Fill & Finish suites based on freeze-drying technologies to increase production capacity in Wavre, Belgium. The facility is expected to be multi-products and compliant with cGMP guidelines for the Korean FDA, US FDA, EU GMP, PIC/S, Japan PMDA and Chinese.
The two suites, one for non-live vaccines (NLV) and one for live vaccines (LVV) are fully independent of each other including personnel/material and logistic areas. Each suite will be fitted out with a formulation area, filling line and lyophilizers.
No Comments